We are the Peptide Experts

JPT Peptide Technologies is the leading manufacturer of custom peptides and innovative peptide-based products for research and clinical applications. For more than 15 years we have been serving the global biomedical community with products and services based on science and quality.

Located in our state-of-the-art laboratories in Berlin, Germany, JPT operates according to the latest ISO 9001:2015 regulations.

Custom Peptide Synthesis

Our Quality Guarantee

Since 2004, JPT has maintained an active quality management system that is reviewed, audited and certified annually by an independent certification body (TÜV Rheinland) to ISO 9001 standards. This includes full process documentation and an early warning system in case of problems.

Product Finder

Filter by

Search by keyword

Research Fields

Cell Therapy & Vaccines

JPT offers a large portfolio of peptide products and services supporting all development phases of new cell therapies and vaccines. These products range from discovery tools for epitope and target identification, to various peptide formats for immune monitoring and clinical grade peptides to support clinical vaccination and cell therapy trials. Learn more

Immunology

JPT has developed a variety of unique peptide-based products allowing systematic evaluation of cellular and humoral immunity. In addition to peptide formats allowing T-cell and B-cell epitope discovery, antigen-specific T-cell stimulation and immune monitoring our clinical grade products support clinical trials for the development of new immunotherapeutics and vaccines. Learn more

Neo-Epitope Discovery & Therapy

Neo-epitopes are important targets for individualized cancer immunotherapy. JPT’s high-throughput peptide techniques enable access to customized peptide products for neo-epitope prioritization and validation, individualized therapy development and immune monitoring. Learn more

Proteomics

Proteomics is the study of a cell's protein inventory at different times by protein identification and quantification. The application of mass spectrometry and more specifically LC-MS/MS has tremendously facilitated this process. JPT developed proprietary approaches for the provision of quantified custom peptides and ready-to-use products enabling protein biomarker identification and quantitation. Learn more

COVID-19

JPT was the first company responding to the Covid-19 pandemic with the launch of a broad SARS CoV-2 genome spanning portfolio of peptide tools. The ready to use and custom peptide tools include antigen spanning PepMixTM peptide pools and PepStarTM peptide microarrays of SARS-CoV-2 wild type and mutated antigen sequences as well as antigens from other relevant corona viruses. Learn more

News

Foto of Aude, Business development Manager USA & Canada

Let me introduce myself! - Aude-Marie Alem

Bonjour everyone! Hi, I am Aude (for my US customers) or Aude-Marie (for my French fellows). I am happy to be part of JPT’s team as Business Development Manager in Boston MA. I am originally from France but lived in multiples countries: France, Ireland, Germany and the USA. I love to be in contact with many different cultures and accents...

Learn more

September 2023

Take Control of Your T Cell Assays!

In a postpandemic world we aim to keep up to date with our new extended CEFSX Ultra Superstim Pool which includes 176 peptide epitopes from 17 known pathogens. JPT is proud to offer an extensive range of peptide-based stimulation controls, facilitating the interpretation of peptide-based T cell stimulation assays.

Learn more

September 2023

Unlocking Proteomics Possibilities: Low Cost Isotope-labeled Peptides in Proteomics

Are you in need of affordable yet reliable isotope labeled peptide standards? Besides our SpikeTides and SpikeMix platforms for tailored large-scale studies, we developed a variety of standardization kits and controls that support QC of proteomics experiments.

Learn more

September 2023